Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2012, Article ID 616125, 3 pages
http://dx.doi.org/10.1155/2012/616125
Case Report

Erythromelalgia: An Uncommon Presentation Precipitated by Aspirin Withdrawal

1Department of Internal Medicine, Henry Ford Hospital, 2799 W Grand Blvd., Detroit, MI 48202, USA
2Department of Internal Medicine, Rawalpindi Medical College, Rawalpindi 46000, Pakistan

Received 30 May 2012; Revised 17 June 2012; Accepted 22 June 2012

Academic Editor: Thomas R. Chauncey

Copyright © 2012 Fatima Khalid et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Eaton and S. Murphy, “Erythromelalgia misdiagnosed as cellulitis,” Cutis, vol. 75, no. 1, pp. 37–40, 2005. View at Google Scholar · View at Scopus
  2. S. Gaur and T. Koroscil, “Late-onset erythromelalgia in a previously healthy young woman: a case report and review of the literature,” Journal of Medical Case Reports, vol. 3, article 106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Crook and J. R. Paranjpe, “Erythromelalgia: a rare cause of extremity pain,” New York State Journal of Medicine, vol. 91, no. 2, pp. 71–72, 1991. View at Google Scholar · View at Scopus
  4. S. Badeloe, C. J. Henquet, C. M. G. Nieuwhof, and J. Frank, “Secondary erythromelalgia involving the ears probably preceding lupus erythematosus,” International Journal of Dermatology, vol. 46, supplement 3, pp. 6–8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. G. H. Thompson, G. Hahn, and M. Rang, “Erythromelalgia,” Clinical Orthopaedics and Related Research, no. 144, pp. 249–254, 1979. View at Google Scholar · View at Scopus
  6. P. J. J. van Genderen and J. J. Michiels, “Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera,” Seminars in Thrombosis and Hemostasis, vol. 23, no. 4, pp. 357–363, 1997. View at Google Scholar · View at Scopus
  7. J. J. Michiels, A. Hagemeyer, and M. E. F. Prins, “Thrombocythaemic erythromelalgia in chronic myeloproliferative and myelodysplastic disorders,” Netherlands Journal of Medicine, vol. 35, no. 1-2, pp. 4–10, 1989. View at Google Scholar · View at Scopus
  8. C. Pipili and E. Cholongitas, “Erythromelalgia in a diabetic patient managed with gabapentin,” Diabetes Research and Clinical Practice, vol. 79, no. 3, pp. e15–e16, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Vendrell, A. Nubiola, A. Goday et al., “Erythromelalgia associated with acute diabetic neuropathy: an unusual condition,” Diabetes Research, vol. 7, no. 3, pp. 149–151, 1988. View at Google Scholar · View at Scopus
  10. W. Cendrowski, “Secondary erythromelalgia in multiple sclerosis,” Wiadomosci Lekarskie, vol. 41, no. 21, pp. 1477–1479, 1988. View at Google Scholar · View at Scopus
  11. A. Kraus, “Erythromelalgia in a patient with systemic lupus erythematosus treated with clonazepam,” Journal of Rheumatology, vol. 17, no. 1, p. 120, 1990. View at Google Scholar · View at Scopus
  12. C. K. Dolan, M. A. Hall, and G. W. Turiansky, “Secondary erythermalgia in an HIV-1-positive patient,” AIDS Reader, vol. 13, no. 2, pp. 91–93, 2003. View at Google Scholar · View at Scopus
  13. G. J. Brodmerkel Jr., “Nifedipine and erythromelalgia,” Annals of Internal Medicine, vol. 99, no. 3, p. 415, 1983. View at Google Scholar · View at Scopus
  14. E. Dupont, F. Illum, and B. De Fine Olivarius, “Bromocriptine and erythromelalgia-like eruptions,” Neurology, vol. 33, no. 5, p. 670, 1983. View at Google Scholar · View at Scopus
  15. S. G. Krishnan, D. P. Yesudian, M. Jayaraman, V. R. Janaki, and B. J. Raj, “Erythromelalgia responding to aspirin,” Indian Journal of Dermatology, Venereology and Leprology, vol. 62, no. 3, pp. 204–205, 1996. View at Google Scholar
  16. M. D. P. Davis, W. M. O'Fallon, R. S. Rogers III, and T. W. Rooke, “Natural history of erythromelalgia: presentation and outcome in 168 patients,” Archives of Dermatology, vol. 136, no. 3, pp. 330–336, 2000. View at Google Scholar · View at Scopus
  17. N. Kumar and M. D. P. Davis, “Erythromelalgia: an underrecognized manifestation of small-fiber neuropathy,” Mayo Clinic Proceedings, vol. 81, no. 8, p. 1001, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Mørk, K. Kvernebo, C. L. Asker, and E. G. Salerud, “Reduced skin capillary density during attacks of erythromelalgia implies arteriovenous shunting as pathogenetic mechanism,” Journal of Investigative Dermatology, vol. 119, no. 4, pp. 949–953, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Mørk, C. L. Asker, E. G. Salerud, and K. Kvernebo, “Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia,” Journal of Investigative Dermatology, vol. 114, no. 4, pp. 643–646, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Nathan, J. B. Rose, J. W. Guite, D. Hehir, and K. Milovcich, “Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment,” Pediatrics, vol. 115, no. 4, pp. e504–e507, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Iqbal, M. I. Bhat, B. A. Charoo, W. A. Syed, M. A. Sheikh, and I. N. Bhat, “Experience with oral mexiletine in primary erythromelalgia in children,” Annals of Saudi Medicine, vol. 29, no. 4, pp. 316–318, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. J. W. Hur, Y. Y. Lee, W. S. Lee, and J. B. Jun, “Erythromelalgia as a presenting manifestation in a patient with essential thrombocythemia complicating renovascular hypertension due to unilateral renal artery stenosis,” Rheumatology International, vol. 26, no. 1, pp. 83–85, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. J. Michiels, “Erythromelalgia and thrombocythemia: a disease of platelet prostaglandin metabolism Thesis, Rotterdam, 1981,” Seminars in Thrombosis and Hemostasis, vol. 23, no. 4, pp. 335–338, 1997. View at Google Scholar · View at Scopus
  24. P. J. J. Van Genderen, J. J. Michiels, R. Van Strik, J. Lindemans, and H. H. D. M. van Vliet, “Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin,” Thrombosis and Haemostasis, vol. 73, no. 2, pp. 210–214, 1995. View at Google Scholar · View at Scopus
  25. A. M. Ceyhan, I. Gurses, M. Yildirim, and V. B. Akkaya, “A case of erythromelalgia: good response to treatment with gabapentin,” Journal of Drugs in Dermatology, vol. 9, no. 5, pp. 565–567, 2010. View at Google Scholar · View at Scopus
  26. J. Natkunarajah, D. Atherton, F. Elmslie, S. Mansour, and P. Mortimer, “Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel,” Clinical and Experimental Dermatology, vol. 34, no. 8, pp. e640–e642, 2009. View at Publisher · View at Google Scholar · View at Scopus